• Taxus chinensis Fruit, TLR4, and Neuroinflammation

  2026-09-20

  A Journal of Ethnopharmacology study reports that Taxus chinensis fruit extract improved aging-associated behavior and neuroinflammatory measures in a D-galactose mouse model. By combining behavioral testing, oxidative-stress profiling, BV2 microglial experiments, UPLC-MS/MS, and molecular docking, the work connects extract-level effects with the TLR4/NF-κB/NLRP3 axis while also identifying testable candidate compounds.

• (-)-Blebbistatin in Cardiac Opto-Electrical Assays

  2026-09-19

  (-)-Blebbistatin can serve as more than a non-muscle myosin II inhibitor: it can help dissect mechanical confounding in cardiac optical and electrical measurements. This article connects its reversible actomyosin mechanism with the POEMS platform and provides a practical framework for interpreting electromechanical experiments.

• SB 203580: Reliable p38 MAPK Assays

  2026-09-18

  Learn how SB 203580 (SKU A8254) can help laboratories distinguish p38 MAPK-dependent biology from nonspecific cytotoxicity while improving compound preparation and assay interpretation. This scenario-based guide covers viability, proliferation, cytotoxicity, formulation, controls, and vendor-selection decisions.

• Dronedarone in AF Research: From Channels to Translation

  2026-09-18

  Dronedarone (Multaq) offers a valuable translational model for studying multi-channel antiarrhythmic pharmacology without assuming that every clinically relevant mechanism is represented by a single ion-channel target. This article connects KCa2.X evidence, assay design, compound handling, and strategic decision-making for atrial fibrillation and atrial flutter research.

• Pregnenolone Carbonitrile: PXR Research Workflows

  2026-09-17

  Pregnenolone Carbonitrile is a practical rodent PXR probe for connecting xenobiotic-response signaling with cytochrome P450 CYP3A induction and hepatic fibrosis assays. This workflow-focused guide shows how to prepare PCN, design controls, interpret cardiac and hepatic readouts, and troubleshoot inconsistent activation without overstating translational relevance.

• FH1 for iPS-Derived Hepatocyte Maturation

  2026-09-17

  FH1 helps turn iPS-derived hepatocyte-like cells into more functional models by improving albumin secretion, CYP3A4 expression, colony morphology, and AFP behavior. This practical guide connects FH1-based maturation workflows with controlled gene-expression assays while emphasizing dose optimization, analytical controls, and translational limitations.

• p-tau Ser356, NUAK1, and Alzheimer’s Pathology

  2026-09-16

  The reference study establishes p-tau Ser356 as a pathology-associated tau species that rises with Alzheimer’s disease progression and is frequently present in neurofibrillary tangles and synaptic compartments. Its brain-slice experiments further show that NUAK inhibition has model-dependent effects, lowering p-tau Ser356 specifically in live human tissue but producing broader tau and neuronal-protein losses in mouse cultures.

• Programmable mRNA for Inflammatory Disc Repair

  2026-09-16

  Inflammatory intervertebral disc degeneration illustrates why mRNA therapeutics increasingly need a cellular delivery strategy. This thought-leadership analysis connects TNF-α biology, LNP-engineered fibroblasts, and disciplined mRNA manufacturing with translational guidance for researchers developing localized regenerative therapies.

• Zolmitriptan: Assay Design Beyond Binding

  2026-09-15

  Zolmitriptan is a selective 5-HT1B receptor agonist for rigorous migraine and cluster headache research. This guide moves beyond target labeling to show how orthogonal assays, solvent controls, and lysosomal-biology insights can improve interpretation without overstating cross-domain evidence.

• (-)-Blebbistatin for Mechanotransduction Studies

  2026-09-15

  Use (-)-Blebbistatin as a reversible, cell-permeable non-muscle myosin II inhibitor to separate actomyosin-generated traction from receptor responses to shear and adhesion. This workflow translates a recent GABAB mechanotransduction finding into practical cytoskeletal dynamics research, cell adhesion and migration studies, and controlled mechanical-stimulation assays.

• Indometacin Sodium: From Mechanism to Translation

  2026-09-14

  Indometacin Sodium Trihydrate offers translational researchers a pathway-aware tool spanning COX biology, prostaglandin synthesis inhibition, pancreatic stellate cell assays, oligodendrocyte differentiation, and reproductive research. This article connects mechanism, assay design, clinical boundaries, and trial-quality thinking beyond the scope of a typical product page.

• TUNEL Apoptosis Detection Kit: Glioma Workflow

  2026-09-14

  Translate DNA fragmentation into clear brown nuclear staining across glioma cultures and tissue sections. This workflow shows how to pair the TUNEL assay with study controls, quantitative imaging, and mechanistic readouts for more defensible programmed cell death research.

• Trichostatin A: A Senescence Assay Strategy

  2026-09-13

  Trichostatin A (TSA) is more than a broad HDAC inhibitor: it can serve as a mechanistic probe for connecting chromatin state, cancer phenotypes, and mitochondrial senescence signaling. This guide translates the TERC-53 findings into a rigorous TSA assay strategy while separating established evidence from testable hypotheses.

• CFDA-SE for Cell Proliferation Tracking

  2026-09-12

  CFDA-SE is a cell-permeable fluorescent reagent for division-resolved labeling of viable cells. Its esterase-activated CFSE product covalently labels intracellular amines, enabling flow cytometry proliferation tracking across immune, stromal, and bacterial models.

• QSHXO Links Autophagy and Ferroptosis in MASLD

  2026-09-11

  Liu et al. report that Qushi Huoxue ointment improves hepatic steatosis and inflammation in a mouse model of metabolic associated steatotic liver disease by coordinating autophagy activation with suppression of ferroptosis-related injury. The study combines histopathology, biochemical testing, serum pharmacochemistry, network pharmacology, molecular assays, and ultrastructural analysis, providing a mechanistic framework for further validation rather than definitive pathway-level proof.

8084 records 1/539 page Next 12345 下5页 Last page